Literature DB >> 8460929

Reproducibility of the microdilution checkerboard method for antibiotic synergy.

K H Rand1, H J Houck, P Brown, D Bennett.   

Abstract

We assessed the reproducibility of the microdilution checkerboard method for measuring antibiotic synergy. Five strains of Pseudomonas aeruginosa were tested with four antibiotic combinations by using 10 replicates each. Twenty-five percent of replicate sets gave discordant classification results (i.e., a 7:3 or worse split in categorization). Determination of the individual MICs of each antibiotic alone was excellent; all 10 replicates were within 1 twofold dilution for 95% of the 80 sets of 10 replicates. The microdilution checkerboard method either should not be used or should be used with at least five replicates per determination, with > or = 80% agreement among the replicates required for classification.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460929      PMCID: PMC187717          DOI: 10.1128/AAC.37.3.613

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

Review 1.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

2.  Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.

Authors:  H O Hallander; K Dornbusch; L Gezelius; K Jacobson; I Karlsson
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

  2 in total
  42 in total

1.  In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection.

Authors:  C Silvestri; O Cirioni; D Arzeni; R Ghiselli; O Simonetti; F Orlando; G Ganzetti; S Staffolani; L Brescini; M Provinciali; A Offidani; M Guerrieri; A Giacometti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-11       Impact factor: 3.267

2.  In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3-carboxamide associated with benznidazole.

Authors:  Rodrigo Hinojosa Valdez; Lilian Tatiani Düsman Tonin; Tânia Ueda-Nakamura; Sueli Oliveira Silva; Benedito Prado Dias Filho; Edilson Nobuyoshi Kaneshima; Sueli Fumie Yamada-Ogatta; Lucy Megumi Yamauchi; Maria Helena Sarragiotto; Celso Vataru Nakamura
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

3.  In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.

Authors:  D W Wareham; D C Bean
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus.

Authors:  Joseph Meletiadis; Spyros Pournaras; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

5.  Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus.

Authors:  Sebastian G Wicha; Martin G Kees; Janin Kuss; Charlotte Kloft
Journal:  Pharm Res       Date:  2015-01-30       Impact factor: 4.200

6.  Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition.

Authors:  Peter A Smith; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

7.  A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.

Authors:  Yang Yang; Zhen Liu; Xiaoqin He; Juanjuan Yang; Jing Wu; Hailong Yang; Min Li; Qian Qian; Ren Lai; Wei Xu; Lin Wei
Journal:  J Biol Chem       Date:  2019-03-20       Impact factor: 5.157

8.  In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates.

Authors:  R C Owens; M A Banevicius; D P Nicolau; C H Nightingale; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

9.  N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.

Authors:  Tiemei Zhao; Youning Liu
Journal:  BMC Microbiol       Date:  2010-05-12       Impact factor: 3.605

10.  Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa.

Authors:  D M Cappelletty; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.